{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:55Z","timestamp":1793442715353,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014417","name":"Fundamental Research Fund of Shandong University","doi-asserted-by":"publisher","award":["2023QNTD001"],"award-info":[{"award-number":["2023QNTD001"]}],"id":[{"id":"10.13039\/100014417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2025YFA0922600"],"award-info":[{"award-number":["2025YFA0922600"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115407","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:45:59Z","timestamp":1790264759000},"page":"115407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PB","title":["Screening strong anaerobic E. coli promoters to enhance therapeutical protein expression in tumors"],"prefix":"10.1016","volume":"399","author":[{"given":"Tianqi","family":"Cui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangle","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanjuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingdi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jconrel.2026.115407_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115407_bb0010","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115407_bb0015","first-page":"86","article-title":"A review of cancer immunotherapy toxicity","volume":"70","author":"Kennedy","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s40425-019-0768-9","article-title":"The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors","volume":"7","author":"Davis","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115407_bb0025","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1073\/pnas.0305877101","article-title":"Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans","volume":"101","author":"Stinear","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115407_bb0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1200\/JCO.2016.67.9258","article-title":"Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis","volume":"35","author":"D\u2019Angelo","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0035","doi-asserted-by":"crossref","first-page":"148","DOI":"10.7150\/thno.79367","article-title":"Blockade of dual immune checkpoint inhibitory signals with a CD47\/PD-L1 bispecific antibody for cancer treatment","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"issue":"18","key":"10.1016\/j.jconrel.2026.115407_bb0040","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1097\/CM9.0000000000002792","article-title":"Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease","volume":"136","author":"Tie","year":"2023","journal-title":"Chin. Med. J."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115407_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/cells9061525","article-title":"Intratumoral versus circulating lymphoid cells as predictive biomarkers in lung cancer patients treated with immune checkpoint inhibitors: is the easiest path the best one?","volume":"9","author":"Gasc\u00f3n","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.115407_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106479","article-title":"Neoadjuvant PD-1\/PD-L1 inhibitors combined with chemotherapy had a higher ORR than mono-immunotherapy in untreated HNSCC: meta-analysis","volume":"145","author":"Chen","year":"2023","journal-title":"Oral Oncol."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115407_bb0055","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1093\/nar\/gkac295","article-title":"Ubiquitous mRNA decay fragments in E. coli redefine the functional transcriptome","volume":"50","author":"Herzel","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.jconrel.2026.115407_bb0060","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-year survival with combined nivolumab and ipilimumab in advanced melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115407_bb0065","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.trecan.2023.04.002","article-title":"Immune mechanisms of toxicity from checkpoint inhibitors","volume":"9","author":"Wang","year":"2023","journal-title":"Trends Cancer"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115407_bb0070","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41571-019-0218-0","article-title":"Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance","volume":"16","author":"Martins","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0075","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41572-020-0160-6","article-title":"Immune-related adverse events of checkpoint inhibitors","volume":"6","author":"Ramos-Casals","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115407_bb0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2934","article-title":"Engineering the perfect (bacterial) cancer therapy","volume":"10","author":"Forbes","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.jconrel.2026.115407_bb0085","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.7150\/thno.42121","article-title":"Imaging of tumor colonization by Escherichia coli using 18F-FDS PET","volume":"10","author":"Kang","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115407_bb0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4068\/cmj.2016.52.3.173","article-title":"Targeted cancer therapy using engineered Salmonella typhimurium","volume":"52","author":"Zheng","year":"2016","journal-title":"Chonnam Med. J."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115407_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0297-0","article-title":"Bacteria-cancer interactions: bacteria-based cancer therapy","volume":"51","author":"Duong","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115407_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003572","article-title":"Bacteria-based cancer immunotherapy","volume":"8","author":"Huang","year":"2021","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115407_bb0105","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41571-024-00908-9","article-title":"Exploiting bacteria for cancer immunotherapy","volume":"21","author":"Kwon","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.jconrel.2026.115407_bb0110","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","article-title":"Tumour-targeting bacteria engineered to fight cancer","volume":"18","author":"Zhou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"issue":"9","key":"10.1016\/j.jconrel.2026.115407_bb0115","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.tips.2022.02.002","article-title":"Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics","volume":"43","author":"Lynch","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.115407_bb0120","article-title":"Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies","volume":"18","author":"Chen","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.115407_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108202","article-title":"Engineering Escherichia coli Nissle 1917 as a microbial chassis for therapeutic and industrial applications","volume":"67","author":"Yu","year":"2023","journal-title":"Biotechnol. Adv."},{"issue":"7882","key":"10.1016\/j.jconrel.2026.115407_bb0130","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41586-021-04003-2","article-title":"Metabolic modulation of tumours with engineered bacteria for immunotherapy","volume":"598","author":"Canale","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16602-0","article-title":"Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity","volume":"11","author":"Leventhal","year":"2020","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.jconrel.2026.115407_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114086","article-title":"T cell cascade regulation initiates systemic antitumor immunity through living drug factory of anti-PD-1\/IL-12 engineered probiotics","volume":"43","author":"Liao","year":"2024","journal-title":"Cell Rep."},{"issue":"8038","key":"10.1016\/j.jconrel.2026.115407_bb0145","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41586-024-08033-4","article-title":"Probiotic neoantigen delivery vectors for precision cancer immunotherapy","volume":"635","author":"Redenti","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29065-2","article-title":"Ultrasound-controllable engineered bacteria for cancer immunotherapy","volume":"13","author":"Abedi","year":"2022","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115407_bb0155","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1038\/mt.2013.183","article-title":"Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent","volume":"21","author":"Jiang","year":"2013","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0160","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11307-023-01879-6","article-title":"Reprogramming a doxycycline-inducible gene switch system for bacteria-mediated cancer therapy","volume":"26","author":"Ngo","year":"2023","journal-title":"Mol. Imaging Biol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11307-021-01624-x","article-title":"Optimized doxycycline-inducible gene expression system for genetic programming of tumor-targeting bacteria","volume":"24","author":"Nguyen","year":"2021","journal-title":"Mol. Imaging Biol."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115407_bb0170","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s10529-020-02851-y","article-title":"Design and evaluation of biological gate circuits and their therapeutic applications in a model of multidrug resistant cancers","volume":"42","author":"Soheili","year":"2020","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.jconrel.2026.115407_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122135","article-title":"Synergistic cancer immunotherapy utilizing programmed Salmonella typhimurium secreting heterologous flagellin B conjugated to interleukin-15 proteins","volume":"298","author":"Zhang","year":"2023","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115407_bb0180","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/sj.bjc.6605403","article-title":"Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice","volume":"101","author":"Ganai","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.115407_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1029403","article-title":"Light-regulated gene expression in bacteria: fundamentals, advances, and perspectives","volume":"10","author":"Ohlendorf","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0190","article-title":"Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field","volume":"14","author":"Ma","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115407_bb0195","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1039\/D1NA00857A","article-title":"Bacteria-mediated tumor immunotherapy via photothermally-programmed PD1 expression","volume":"4","author":"Xu","year":"2022","journal-title":"Nanoscale Adv."},{"issue":"15","key":"10.1016\/j.jconrel.2026.115407_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202105086","article-title":"Bacteria-elicited specific thrombosis utilizing acid-induced cytolysin a expression to enable potent tumor therapy","volume":"9","author":"Qin","year":"2022","journal-title":"Adv. Sci."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115407_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/bios13020266","article-title":"Genetic programming by nitric oxide-sensing gene switch system in tumor-targeting bacteria","volume":"13","author":"Qin","year":"2023","journal-title":"Biosensors"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115407_bb0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/gt.2008.188","article-title":"Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors","volume":"16","author":"Ryan","year":"2009","journal-title":"Gene Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115407_bb0215","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1021\/acssynbio.6b00233","article-title":"Characterization of endogenous and reduced promoters for oxygen-limited processes using Escherichia coli","volume":"6","author":"Lara","year":"2016","journal-title":"ACS Synth. Biol."},{"issue":"530","key":"10.1016\/j.jconrel.2026.115407_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax0876","article-title":"Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies","volume":"12","author":"Gurbatri","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115407_bb0225","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/biot.201200383","article-title":"Synthetic biology of avermectin for production improvement and structure diversification","volume":"9","author":"Zhuo","year":"2014","journal-title":"Biotechnol. J."},{"issue":"7","key":"10.1016\/j.jconrel.2026.115407_bb0230","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nprot.2016.054","article-title":"RecET direct cloning and red\u03b1\u03b2 recombineering of biosynthetic gene clusters, large operons or single genes for heterologous expression","volume":"11","author":"Wang","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2026.115407_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/1475-2859-11-145","article-title":"Modulation of endogenous pathways enhances bioethanol yield and productivity in Escherichia coli","volume":"11","author":"Munjal","year":"2012","journal-title":"Microb. Cell Factories"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27010294","article-title":"Biosynthesis of poly-(3-hydroxybutyrate) under the control of an anaerobically induced promoter by recombinant Escherichia coli from sucrose","volume":"27","author":"Wu","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115407_bb0245","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10529-007-9544-x","article-title":"Engineering a native homoethanol pathway in Escherichia coli B for ethanol production","volume":"30","author":"Zhou","year":"2008","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.jconrel.2026.115407_bb0250","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ymben.2023.04.006","article-title":"Characterizing and utilizing oxygen-dependent promoters for efficient dynamic metabolic engineering","volume":"77","author":"Wichmann","year":"2023","journal-title":"Metab. Eng."},{"issue":"24","key":"10.1016\/j.jconrel.2026.115407_bb0255","doi-asserted-by":"crossref","first-page":"10013","DOI":"10.1007\/s00253-014-6059-y","article-title":"Effects of cascaded vgb promoters on poly(hydroxybutyrate) (PHB) synthesis by recombinant Escherichia coli grown micro-aerobically","volume":"98","author":"Wu","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115407_bb0260","article-title":"Benzosceptrin C induces lysosomal degradation of PD-L1 and promotes antitumor immunity by targeting DHHC3","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115407_bb0265","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.synbio.2024.01.006","article-title":"Minimizing endogenous cryptic plasmids to construct antibiotic-free expression systems for Escherichia coli Nissle 1917","volume":"9","author":"Zhou","year":"2024","journal-title":"Synth. Syst. Biotechnol."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115407_bb0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-2958.1995.mmi_17020211.x","article-title":"Comparison of ccd of F, parDE of RP4, and parD of R1 using a novel conditional replication control system of plasmid R1","volume":"17","author":"Jensen","year":"1995","journal-title":"Mol. Microbiol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:50:17Z","timestamp":1793440217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":54,"alternative-id":["S0168365926008114"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115407","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening strong anaerobic E. coli promoters to enhance therapeutical protein expression in tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115407"}}